{"comparisonGroups":["Baseline","Post-Intervention"],"dateCreated":"2025-09-26 00:00:00","display_title":"Baseline vs 6-month lifestyle intervention","group_a_title":"Samples collected at baseline (0 months) before intervention.. Serves as the reference point for evaluating the effects of the lifestyle intervention.","group_b_title":"Samples collected after 6 months of lifestyle intervention.. Critical for assessing the impact of the lifestyle intervention on metabolic signatures.","id":"MTBLS423_0002_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":2,"studyId":"MTBLS423","studyUrl":"http://integmet.org/study/MTBLS423","title":"Baseline_vs_Post-Intervention","topHits":[{"chebi_id":"84765","direction":"up","inn_name":"","iupac_name":"(15<i>Z</i>)-<em>N</em>-[(2<i>S</i>,3<i>R</i>,4<i>E</i>)-1-{[4-<em>O</em>-(\u03b2-<small>D</small>-galactopyranosyl)-\u03b2-<small>D</small>-glucopyranosyl]oxy}-3-hydroxyoctadec-4-en-2-yl]tetracos-15-enamide","metabolite_id":"MKOKWBRPIBQYJJ-WZBOJYASSA-N","pvalue":5.809176959896546e-05,"ratio":1.626053125289568,"synonym_name":"N-(15Z-tetracosenoyl)-1-b-lactosyl-sphing-4-enine"},{"chebi_id":"72962","direction":"up","inn_name":"","iupac_name":"<em>N</em>-[(2<i>S</i>,3<i>R</i>,4<i>E</i>)-1,3-dihydroxyoctadec-4-en-2-yl]icosanamide","metabolite_id":"XWBWIAOWSABHFI-NUKVNZTCSA-N","pvalue":9.043656981884132e-05,"ratio":1.5302429106282358,"synonym_name":"<em>N</em>-(eicosanoyl)ceramide"}],"totalFeatures":6}